Practice Matters

Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy

Umesh Yogarajah, PharmD, BCOP,Thuy Tran, PharmD, BCOP, CSP,Erin Cichonski, PharmD,et al.

A pharmacist-led clinical support program was implemented across a large health-care network in order to standardize and improve the care of patients with polycythemia vera. Pharmacists provided clinical reviews, pharmacotherapy recommen...

July 01, 2026

Grand Rounds

Capecitabine-Induced Hand-Foot Syndrome With Genital Involvement

Yue Feng, APRN,Christina Baroody, PharmD, BCOP,Salwan Al Mutar, MD, MS et al.

This case report describes a 59-year-old man with metastatic pancreatic ductal adenocarcinoma who developed capecitabine-associated hand-foot syndrome with rare genital involvement, highlighting the need to recognize atypical presentatio...

July 01, 2026

Grand Rounds

Concurrent Ocular and Dermatologic Toxicities Associated With Docetaxel Chemotherapy

Jaimie A. Wittig, PharmD, BCOP,Jennifer Grabowski, PharmD, BCOP,Sarah C. Villani, FNP-C, MSN,et al.

Two cases of ocular and dermatologic toxicities caused by docetaxel highlight the importance of rapid identification and intervention under the care of both the oncology team and an ophthalmologist.

July 01, 2026

Research and Scholarship

Fixed Treatment Duration Mosunetuzumab in Patients With Relapsed or Refractory Follicular Lymphoma: Perspectives From US Advanced Practice Providers

Maria D. Guerrero, DNP, NP-C, AOCNP ,Barbara Averill, BSN, RN, CCRP,Lauren Clermont, DNP, NP-C, AOCNP, BMTCN,et al.

This article describes the perspectives of advanced practice providers on their role in the education, monitoring, and management of adverse events in patients with relapsed or refractory follicular lymphoma treated with mosunetuzumab IV...

July 01, 2026

Research and Scholarship

Assessment of Advanced Practitioner Oncogenomic Training and Proficiency Before and After the Intervention of an Oncogenomic Module

Sarah Moncado, PA-C,Janice S. Withycombe, PhD, RN, MN, FAAN,Diana Ivankovic, PhD,et al.

This study evaluated the importance of genetics/genomics training for advanced practitioners (APs) working in hematology/oncology, finding that a focused oncogenomic course for APs is an effective learning strategy.

July 01, 2026

Practice Matters

Building Bridges: The Impact of Medical Science Liaison and Advanced Practice Provider Collaborations

Katherine Albert, DNP, AOCNP,Kristina Byers, PharmD, BCOP,Chelsey Boggs, NP, MSN, BSN, OCN et al.

Collaboration between medical science liaisons (MSLs) and advanced practice providers (APPs) is essential for advancing oncology care in an increasingly complex treatment landscape. This article outlines the origins and responsibilities ...

May 06, 2026

Grand Rounds

Colorectal Cancer Treatment During Pregnancy

Kathryn L. Green, MSN, CRNP,Rachel Hatch, PharmD, BCOP

Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer trea...

May 06, 2026

Grand Rounds

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy

Maria D. Guerrero, DNP, NP-C, AOCNP

One of the most promising developments in advanced-stage Hodgkin lymphoma is the nivolumab-AVD regimen, which combines nivolumab with doxorubicin, vinblastine, and dacarbazine. This article provides practical knowledge for advanced pract...

May 06, 2026

Grand Rounds

A Comprehensive Review of Monoclonal Gammopathy of Undetermined Significance

Kimberly Noonan, DNP, ANP-BC, AOCN, FAAN,Kevin Brigle, PhD, ANP,Charise Gleason, MSN, NP-C, AOCNP,et al.

Approximately 3% to 4% of the population over the age of 50 is diagnosed with monoclonal gammopathy of undetermined significance (MGUS). It carries a lifelong risk of progression to multiple myeloma and lymphoma, requiring risk-adapted m...

March 04, 2026

Review Article

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

Mark Davis, PA-C, DMSc (candidate)

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet thera...

May 06, 2026

Research and Scholarship

Retrospective Characterization of Specialized Palliative Care in Patients With Gliomas

Sisse Josephine Rudkjøbing, MD,Katrine Rahbek Schønnemann, MD, PhD,Jesper Rahr Lauritsen, MD,et al.

Patients with gliomas face significant challenges in daily life due to rapidly progressing neurological and cognitive symptoms. This study evaluated referral processes for specialized palliative care and interdisciplinary services used b...

May 06, 2026

Research and Scholarship

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals

Heather Sloan, BSN, MSN, APRN,Sarah J. Jennings, DNP, MPA, RN,Kristi Adair, PhD, RN,et al.

This quality improvement project found that using a distress screening tool for head and neck cancer patients who were 2 or more years post-treatment led to an increased number of referrals for psychosocial needs.

May 06, 2026

Practice Matters

The Promise of Artificial Intelligence to Aid in Systematic Reviews: An Examination of Scopus AI

Lydia T. Madsen, PhD, RN, AOCNS, FNAP,John C. Carter, MLIS, AHIP,Sheeba Cantanelli, MPAS, PA-C,et al.

AI tools such as Scopus AI can aid APP researchers and clinicians to streamline specific aspects such as the initial tasks and literature search steps of the systematic review development process.

March 04, 2026

Practice Matters

Advanced Practice Providers in Oncology Care: Consensus Principles for Clinical Practice Utilization

Dori L. Klemanski, DNP, APRN-CNP,Terry Harrington, MS,Lindsey Bandini, MPH,et al.

The NCCN’s Best Practice Committee APP workgroup generated consensus principles to optimize the potential of APPs.

March 04, 2026

Research and Scholarship

Characterizing the Clinical Role of Radiation Oncology Advanced Practice Providers Using Entrustable Professional Activities

Brett S. Wagner, BA,Levi Martinka, MD,Drew Gordon, BA,et al.

This study elucidates clinical responsibilities of current US radiation oncology APPs in order to inform educational needs.

March 04, 2026

Research and Scholarship

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program

Michael Tarantino, MD,David Dubinski, MBA,Corey Falcon, MD,et al.

Immune thrombocytopenia (ITP) is a rare autoimmune disorder resulting in reduced platelet count. This quality improvement study facilitated conversations between health-care providers, adult patients, and caregivers of pediatric patients...

March 09, 2026

Diagnostic Snapshot

Can a Benign Hematology Phenomenon Critically Impact the Neutropenia Status and Treatment of Patients With Cancer?

Amandine P. Ndje, MS, MBA, APRN, FNP-C

Neutropenia in oncology care usually has a disease-related or therapy-related etiology. However, for a population with a benign hematology phenomenon known as benign ethnic neutropenia (BEN) or Duffy-null associated neutrophil count (DAN...

January 09, 2026

Considerations in Prescribing

Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura

Taylor P. Robichaux, PharmD, BCPS, CACP,Kathryn E. Dane, PharmD, BCPS,P. Christopher Parish, PharmD, BCOP,et al.

Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare autosomal recessive condition that causes deficiency of the von Willebrand factor (vWF)-cleaving metalloprotease, ADAMTS13. Recombinant ADAMTS13 (rADAMTS13) is the first FD...

January 09, 2026

Practice Matters

Narrative Medicine: A Clinical Tool for the Oncology Advanced Practitioner

Jonathan Cunningham, MPAS, PA-C

Narrative medicine, a structured approach to engaging with patients’ stories, can help oncology advanced practitioners foster better engagement and understanding. This article details practical tools such as attentive listening, reflecti...

January 09, 2026

Grand Rounds

A Rare Case of Acute Hemolysis After Rasburicase Infusion

Jacqueline B. Broadway-Duren, PhD, DNP, APRN, FNP-BC,Taylor P. Gardiner, MPAS

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic X-linked recessive disorder that results from mutations in the G6PD gene, which provides instructions for manufacturing the G6PD enzyme. G6PD deficiency can result in hemol...

January 09, 2026

Research and Scholarship

Integrative Oncology Models of Care: Practice Patterns From NCCN Member Institutions

Angela F. Bazzell, DNP, APRN, FNP-BC, AOCNP,Lydia T. Madsen, PhD, RN, AOCNS, FNAP,Lindsey Bandini, MPH,et al.

Patients with cancer frequently incorporate complementary modalities into their care. A survey of 29 NCCN Member Institutions revealed details on how integrative oncology services are delivered, including the types of services provided, ...

January 09, 2026

Meeting Abstracts

Clinical Posters From JADPRO Live 2025

Forty-four clinical posters focused on the role of the advanced practitioner were presented at JADPRO Live from October 23 to 26, 2025, in National Harbor, Maryland.

January 09, 2026